Levetiracetam Treatment of Tardive Dyskinesia

Summary

This is a placebo-controlled study designed to learn if levetiracetam is effective for tardive dyskinesia.

Timeline

Start

—

Primary completion

2006-04

Completion

—

Outcome

Met primary endpoint

paper AIMS total scores declined 43.5% from baseline in the levetiracetam group compared to 18.7% for placebo (p = .022). PMID 18312060 ↗

Publications

• Woods SW, Saksa JR, Baker CB, Cohen SJ, Tek C. Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2008 Apr;69(4):546-54. doi: 10.4088/jcp.v69n0405.

Drugs

Indications